Lonial Sagar
TG Therapeutics, Inc. · Director
Lonial Sagar is listed in filings as Director at TG Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 12, 2025, including sale activity. Recent filings connect the profile to TG Therapeutics, Inc. (TGTX). The current snapshot covers public activity from Jun 20, 2024 to Sep 12, 2025. Reported amounts are shown as $157.1K to $152.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $157k9.6k shares | SellJun 17, 2024 | $16.39 | $54.93 | |
| $276k16.3k shares | SellJun 20, 2024 | $16.87 | $54.93 | |
| $152k5k shares | SellNov 11, 2024 | $30.44 | $54.93 |